Right Brain Bio uses human intelligence to identify diseases with contradictions or inconsistencies in their foundational assumptions in pursuit of new therapeutic strategies.
Our lead product provides dopamine reduction therapy for Parkinson's disease, which is ready to enter Phase 2A clinical trials.
Company Details
- Founded
- -
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://rightbrainbio.com
- Keywords
- Parkinson's.
Right Brain Bio, Inc. Questions
Right Brain Bio, Inc.'s website is https://rightbrainbio.com
Right Brain Bio, Inc.'s LinkedIn profile is https://www.linkedin.com/company/right-brain-bio
Right Brain Bio, Inc.'s industry is
Biotechnology Research
Right Brain Bio, Inc.'s top competitors are
Alzamend Neuro,
Oligomerix, Inc,
Montara Therapeutics, Inc.,
C2n Diagnostics,
Myrobalan Therapeutics,
Quralis,
Dogwood Therapeutics,
Suven Pharmaceuticals,
Kaerus Bioscience Ltd.,
Okyo Pharma.
Right Brain Bio, Inc.'s categories are Biotechnology Research
Right Brain Bio, Inc.'s founding year is 2022
